These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37907529)

  • 21. Inducible expression of tissue factor in small-cell lung cancer: impact on morphology and matrix metalloproteinase secretion.
    Hahn N; Heiden M; Seitz R; Salge-Bartels U
    J Cancer Res Clin Oncol; 2012 Apr; 138(4):695-703. PubMed ID: 22237453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MAX inactivation in small cell lung cancer disrupts MYC-SWI/SNF programs and is synthetic lethal with BRG1.
    Romero OA; Torres-Diz M; Pros E; Savola S; Gomez A; Moran S; Saez C; Iwakawa R; Villanueva A; Montuenga LM; Kohno T; Yokota J; Sanchez-Cespedes M
    Cancer Discov; 2014 Mar; 4(3):292-303. PubMed ID: 24362264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Key Biomarkers and Pathways in Small-Cell Lung Cancer Using Biological Analysis.
    Liu H; Li T; Ye X; Lyu J
    Biomed Res Int; 2021; 2021():5953386. PubMed ID: 34712733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristics and patient outcomes of molecular subtypes of small cell lung cancer (SCLC).
    Ding XL; Su YG; Yu L; Bai ZL; Bai XH; Chen XZ; Yang X; Zhao R; He JX; Wang YY
    World J Surg Oncol; 2022 Feb; 20(1):54. PubMed ID: 35220975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ascl1-induced Wnt11 regulates neuroendocrine differentiation, cell proliferation, and E-cadherin expression in small-cell lung cancer and Wnt11 regulates small-cell lung cancer biology.
    Tenjin Y; Kudoh S; Kubota S; Yamada T; Matsuo A; Sato Y; Ichimura T; Kohrogi H; Sashida G; Sakagami T; Ito T
    Lab Invest; 2019 Nov; 99(11):1622-1635. PubMed ID: 31231131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathological and genomic comparisons between different histologic components in combined small cell lung cancer and non-small cell lung cancer.
    Lin MW; Su KY; Su TJ; Chang CC; Lin JW; Lee YH; Yu SL; Chen JS; Hsieh MS
    Lung Cancer; 2018 Nov; 125():282-290. PubMed ID: 30429033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ARHGEF19 regulates MAPK/ERK signaling and promotes the progression of small cell lung cancer.
    Wang Z; Kan G; Sheng C; Yao C; Mao Y; Chen S
    Biochem Biophys Res Commun; 2020 Dec; 533(4):792-799. PubMed ID: 32993957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An in silico comparative transcriptome analysis identifying hub lncRNAs and mRNAs in brain metastatic small cell lung cancer (SCLC).
    Mikaeili Namini A; Jahangir M; Mohseni M; Kolahi AA; Hassanian-Moghaddam H; Mazloumi Z; Motallebi M; Sheikhpour M; Movafagh A
    Sci Rep; 2022 Oct; 12(1):18063. PubMed ID: 36302939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. m
    Zhang Z; Zhang C; Yang Z; Zhang G; Wu P; Luo Y; Zeng Q; Wang L; Xue Q; Zhang Y; Sun N; He J
    J Hematol Oncol; 2021 Nov; 14(1):190. PubMed ID: 34758859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ASCL1 regulates super-enhancer-associated miRNAs to define molecular subtypes of small cell lung cancer.
    Miyakawa K; Miyashita N; Horie M; Terasaki Y; Tanaka H; Urushiyama H; Fukuda K; Okabe Y; Ishii T; Kuwahara N; Suzuki HI; Nagase T; Saito A
    Cancer Sci; 2022 Nov; 113(11):3932-3946. PubMed ID: 35789143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prototypical oncogene family Myc defines unappreciated distinct lineage states of small cell lung cancer.
    Patel AS; Yoo S; Kong R; Sato T; Sinha A; Karam S; Bao L; Fridrikh M; Emoto K; Nudelman G; Powell CA; Beasley MB; Zhu J; Watanabe H
    Sci Adv; 2021 Jan; 7(5):. PubMed ID: 33514539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitivity of Small Cell Lung Cancer to BET Inhibition Is Mediated by Regulation of ASCL1 Gene Expression.
    Lenhart R; Kirov S; Desilva H; Cao J; Lei M; Johnston K; Peterson R; Schweizer L; Purandare A; Ross-Macdonald P; Fairchild C; Wong T; Wee S
    Mol Cancer Ther; 2015 Oct; 14(10):2167-74. PubMed ID: 26253517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential Proteomic Analysis between Small Cell Lung Carcinoma (SCLC) and Pulmonary Carcinoid Tumors Reveals Molecular Signatures for Malignancy in Lung Cancer.
    Fujii K; Miyata Y; Takahashi I; Koizumi H; Saji H; Hoshikawa M; Takagi M; Nishimura T; Nakamura H
    Proteomics Clin Appl; 2018 Nov; 12(6):e1800015. PubMed ID: 29888431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular subtype expression and genomic profiling differ between surgically resected pure and combined small cell lung carcinoma.
    Zhu Y; Li S; Wang H; Chi K; Ren W; Huang X; Zhuo M; Lin D
    Hum Pathol; 2023 Nov; 141():118-129. PubMed ID: 37586462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An integrative transcriptome analysis reveals a functional role for thyroid transcription factor-1 in small cell lung cancer.
    Horie M; Miyashita N; Mattsson JSM; Mikami Y; Sandelin M; Brunnström H; Micke P; Nagase T; Saito A
    J Pathol; 2018 Oct; 246(2):154-165. PubMed ID: 29876935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcription Factors Contribute to Differential Expression in Cellular Pathways in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Liu S; Wang X; Qin W; Genchev GZ; Lu H
    Interdiscip Sci; 2018 Dec; 10(4):836-847. PubMed ID: 30039492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ASCL1 regulates the expression of the CHRNA5/A3/B4 lung cancer susceptibility locus.
    Improgo MR; Schlichting NA; Cortes RY; Zhao-Shea R; Tapper AR; Gardner PD
    Mol Cancer Res; 2010 Feb; 8(2):194-203. PubMed ID: 20124469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A global view of regulatory networks in lung cancer: An approach to understand homogeneity and heterogeneity.
    Lu J; Wang W; Xu M; Li Y; Chen C; Wang X
    Semin Cancer Biol; 2017 Feb; 42():31-38. PubMed ID: 27894849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of Gene Biomarkers for Distinguishing Small-Cell Lung Cancer from Non-Small-Cell Lung Cancer Using a Network-Based Approach.
    Long F; Su JH; Liang B; Su LL; Jiang SJ
    Biomed Res Int; 2015; 2015():685303. PubMed ID: 26290870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subtype-specific secretomic characterization of pulmonary neuroendocrine tumor cells.
    Wang XD; Hu R; Ding Q; Savage TK; Huffman KE; Williams N; Cobb MH; Minna JD; Johnson JE; Yu Y
    Nat Commun; 2019 Jul; 10(1):3201. PubMed ID: 31324758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.